Abstract:Objective: To evaluate the obstetrical and oncological progression of twin pregnancies with hydatidiform mole coexisting fetus (HMCF). Materials and methods: Using a retrospective method based on patients from the Women's Hospital, Zhejiang University School of Medicine database between January 1990 and October 2020, 17 patients were histologically confirmed as having HMCF, and the patients' prenatal diagnosis, outcomes and development of gestational trophoblastic neoplasia (GTN) were reviewed. Results: Among these 17 cases, 11 (64.71%) cases were complete hydatidiform mole coexisting fetus (CHMCF), and 6 (35.29%) cases were partial hydatidiform mole coexisting fetus (PHMCF). The gestational age at diagnosis of CHMCF was significantly earlier than that of PHMCF [9 (8-24) vs. 18 (11-32) weeks, respectively, P < 0.05]. The live birth rate of PHMCF was slightly higher than that of CHMCF (33.33%; 18.18%), but this difference was not statistically significant. The overall rate of GTN incidence of HMCF was 47.06% (8/17), and the GTN rates of PHMCF and CHMCF were 33.33% (2/6) and 54.55% (6/11), respectively. There was no significant difference in the GTN rate between patients who chose to continue pregnancy and those who terminated pregnancy before 24 weeks of gestation. The GTN rate of patients with term delivery was not significantly higher than that of preterm delivery. Conclusion: In HMCF cases, the incidence rate of CHMCF was higher than that of PHMCF, and PHMCF is more difficult to diagnose in the early stage. Continuing pregnancy does not increase the risk of GTN compared to terminating pregnancy. In cases of HMCF, when the fetal karyotype is normal and maternal complications are controlled, it is safe to continue the pregnancy and extend it to term.

EP21.15: Ultrasound findings: from twin pregnancy with complete hydatidiform mole and coexistent fetus to invasive mole and resolution

EP22.37: Partial hydatidiform mole with a coexisting live fetus: a case report

Twin Pregnancy with Complete Hydatidiform Mole and Co-Existing Fetus: A Report of 15 Cases with a Clinicopathological Analysis and DNA Genotyping.

Complete hydatidiform mole in a triplet pregnancy coexisting two viable fetuses: Case report and review of the literature

Triplet Pregnancy with a Complete Hydatidiform Mole and Two Live Fetuses: A Case Report

Serial hCG and ultrasound measurements for predicting malignant potential in multiple pregnancies associated with complete hydatidiform mole: a report of 2 cases

EP20.26: Recurrent invasive mole within the myometrium

Twin pregnancy consisting of a complete hydatidiform mole and coexistent fetus: a clinicopathological analysis

Obstetrical and oncological outcomes of twin pregnancies with hydatidiform mole and coexisting fetus

Hydatidiform mole with coexisting fetus: a clinicopathologic analysis of 4 cases

OC17.03: Correlation of SNP‐based prenatal cfDNA and clinical findings of a complete mole with a coexisting fetus

Triplet pregnancy with partial hydatidiform mole coexisting with two fetuses: a case report

Triplet pregnancy with partial hydatiform mole

EP06.23: Ultrasound in diagnosing major congenital structural anomalies throughout pregnancy

EP25.18: Ultrasound screening of Müllerian anomalies

EP14.13: Anastomosis placentarias en embarazos gemelares monocoriónicos: estudio mediante técnicas de inyección vascular y relación con complicaciones fetales

EP21.38: Atypical presentation of invasive mole in a perimenopausal woman

Triplet pregnancy with hydatidiform mole: A report of two cases with literature review

OC04.05: Ultrasound imaging and hysteroscopy findings in patients referred with atypical placental site nodule to a tertiary gestational trophoblastic centre

EP05.41: Alpha thalassemia major and malformation of cortical development: is it an incidental finding or truly related?